Gene · 9378
Papers2,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic analysis of copy number variants of uncertain significance partially overlapping with the haploinsufficient or triplosensitive genes in clinical testing. | Ann Med | 2023 | 37917952 | PubTator, text mining | PubMed |
| Glioma synapses recruit mechanisms of adaptive plasticity. | Nature | 2023 | 37914930 | PubTator, text mining | PubMed |
| Differential DNA Methylation from Autistic Children Enriches Evidence for Genes Associated with ASD and New Candidate Genes. | Brain Sci | 2023 | 37891789 | PubTator, text mining | PubMed |
| Population-based Risk of Psychiatric Disorders Associated with Recurrent CNVs. | medRxiv | 2023 | 37886536 | PubTator, text mining | PubMed |
| Copy Number Variants Increasing Risk for Schizophrenia: Shared and Distinct Effects on Brain Morphometry and Cognitive Performance. | Biol Psychiatry Glob Open Sci | 2023 | 37881570 | PubTator, text mining | PubMed |
| RNA modification regulator DDC in endometrial cancer affects the tumor microenvironment and patient prognosis. | Sci Rep | 2023 | 37872211 | PubTator, text mining | PubMed |
| Genomic findings in schizophrenia and their implications. | Mol Psychiatry | 2023 | 37853064 | PubTator, text mining | PubMed |
| Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets. | EBioMedicine | 2023 | 37837931 | PubTator, text mining | PubMed |
| PSD95 as a New Potential Therapeutic Target of Osteoarthritis: A Study of the Identification of Hub Genes through Self-Contrast Model. | Int J Mol Sci | 2023 | 37834131 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model. | Front Oncol | 2023 | 37817770 | PubTator, text mining | PubMed |
| Retracted: miR-196a-2 Promotes Malignant Progression of Thyroid Carcinoma by Targeting NRXN1. | Comput Math Methods Med | 2023 | 37811215 | PubTator, text mining | PubMed |
| SOX7: Novel Autistic Gene Identified by Analysis of Multi-Omics Data. | Res Sq | 2023 | 37790478 | PubTator, text mining | PubMed |
| Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor. | bioRxiv | 2023 | 37790460 | PubTator, text mining | PubMed |
| Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas. | Acta Neuropathol Commun | 2023 | 37770931 | PubTator, text mining | PubMed |
| Copy Number Variations in Neuropsychiatric Disorders. | Int J Mol Sci | 2023 | 37761973 | PubTator, text mining | PubMed |
| Detection of N‑glycoprotein associated with IgA nephropathy in urine as a potential diagnostic biomarker using glycosylated proteomic analysis. | Exp Ther Med | 2023 | 37753295 | PubTator, text mining | PubMed |
| Expression of the schizophrenia associated gene FEZ1 in the early developing fetal human forebrain. | Front Neurosci | 2023 | 37746155 | PubTator, text mining | PubMed |
| Bibliometric analysis of research on neurodegenerative diseases and single-cell RNA sequencing: Opportunities and challenges. | iScience | 2023 | 37736042 | PubTator, text mining | PubMed |
| Defining and identifying cell sub-crosstalk pairs for characterizing cell-cell communication patterns. | Sci Rep | 2023 | 37735248 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor Receptor 2 (FGFR2), a New Gene Involved in the Genesis of Autism Spectrum Disorder. | Neuromolecular Med | 2023 | 37733178 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9378/papers?page=9